Baker Bros. Advisors LP Design Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $7.9 Billion
- Q1 2024
A detailed history of Baker Bros. Advisors LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 1,662,120 shares of DSGN stock, worth $5.5 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
1,662,120
Previous 1,500,000
10.81%
Holding current value
$5.5 Million
Previous $3.98 Million
68.5%
% of portfolio
0.08%
Previous 0.05%
Shares
6 transactions
Others Institutions Holding DSGN
# of Institutions
95Shares Held
30.5MCall Options Held
100Put Options Held
100-
Sr One Capital Management, LP6.53MShares$21.6 Million8.85% of portfolio
-
Logos Global Management LP San Francisco, CA5.03MShares$16.7 Million1.89% of portfolio
-
Black Rock Inc. New York, NY2.27MShares$7.53 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA1.48MShares$4.9 Million0.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.29MShares$4.26 Million0.0% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $185M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...